Oral monthly ibandronate: rationale and clinical potential in postmenopausal osteoporosis

Jean-Yves Reginster; M. McClung; K. Coutant; B. Bonvoisin; R. C. Schimmer; P. D. Delmas

Back

Oral monthly ibandronate: rationale and clinical potential in postmenopausal osteoporosis

Conference proceeding

Peer reviewed

Oral monthly ibandronate: rationale and clinical potential in postmenopausal osteoporosis

Jean-Yves Reginster, M. McClung, K. Coutant, B. Bonvoisin, R. C. Schimmer and P. D. Delmas

Annals of the Rheumatic Diseases (2003-06); Congress of the European League Against Rheumatism (EULAR 2003), Lisbon, Portugal [PT], du 18 juin 2003 au 21 juin 2003

06/2003

Abstract

General & internal medicine

Human health sciences

Médecine générale & interne

Rheumatology

Rhumatologie

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: Oral monthly ibandronate: rationale and clinical potential in postmenopausal osteoporosis
Creators - without role: Jean-Yves Reginster
M. McClung
K. Coutant
B. Bonvoisin
R. C. Schimmer
P. D. Delmas
Conference: Annals of the Rheumatic Diseases (2003-06); Congress of the European League Against Rheumatism (EULAR 2003), Lisbon, Portugal [PT], du 18 juin 2003 au 21 juin 2003
Publisher: BMJ Group
Identifiers: 9952142208331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding